secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001193125-23-249192
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal raises ~$472M in stock/warrant offering to fund resmetirom launch prep
-------------------------------------------------------------------------------

- Offering of 1,248,098 shares at $151.69 and 2,048,098 pre-funded warrants at $151.6899 per warrant.
- Estimated net proceeds ~$472M (excluding underwriter's option); closing expected Oct 3, 2023.
- Proceeds for clinical/commercial activities for potential U.S. launch of resmetirom and general corporate purposes.
- Underwriters have 30-day option to purchase up to 494,429 additional shares.
- Directors and executive officers subject to 60-day lock-up without underwriter consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523249192/0001193125-23-249192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523249192/d485845d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-249192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer